Cytosorbents Corporation (CTSO)
USD 0.99
(-1.0%)
USD 0.99
(-1.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 48.33 Million USD | 12.83% |
| 2022 | 46.92 Million USD | -9.42% |
| 2021 | 51.8 Million USD | 33.62% |
| 2020 | 38.77 Million USD | 12.78% |
| 2019 | 34.37 Million USD | 21.26% |
| 2018 | 28.34 Million USD | 60.1% |
| 2017 | 17.7 Million USD | 12.46% |
| 2016 | 15.74 Million USD | 41.25% |
| 2015 | 11.14 Million USD | 34.46% |
| 2014 | 8.29 Million USD | 128.79% |
| 2013 | 3.62 Million USD | 9.04% |
| 2012 | 3.32 Million USD | -25.51% |
| 2011 | 4.46 Million USD | 57.97% |
| 2010 | 2.82 Million USD | -6.72% |
| 2009 | 3.02 Million USD | -6.68% |
| 2008 | 3.24 Million USD | 5.79% |
| 2007 | 3.06 Million USD | 3.45% |
| 2006 | 2.96 Million USD | 3605.39% |
| 2005 | 80 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 11.43 Million USD | -21.01% |
| 2024 Q2 | 9.73 Million USD | -14.83% |
| 2023 Q4 | 14.47 Million USD | 21.62% |
| 2023 Q2 | 11.22 Million USD | -4.9% |
| 2023 Q1 | 11.8 Million USD | 13.92% |
| 2023 Q3 | 11.9 Million USD | 5.97% |
| 2023 FY | 52.94 Million USD | 12.83% |
| 2022 Q3 | 10.98 Million USD | -9.48% |
| 2022 Q4 | 10.36 Million USD | -5.65% |
| 2022 Q2 | 12.13 Million USD | -9.68% |
| 2022 FY | 46.92 Million USD | -9.42% |
| 2022 Q1 | 13.43 Million USD | -16.72% |
| 2021 Q4 | 16.13 Million USD | 36.23% |
| 2021 FY | 51.8 Million USD | 33.62% |
| 2021 Q1 | 10.24 Million USD | -11.97% |
| 2021 Q2 | 13.57 Million USD | 32.56% |
| 2021 Q3 | 11.84 Million USD | -12.78% |
| 2020 Q1 | 8.25 Million USD | -17.06% |
| 2020 Q2 | 9.56 Million USD | 15.98% |
| 2020 Q4 | 11.63 Million USD | 24.93% |
| 2020 Q3 | 9.31 Million USD | -2.65% |
| 2020 FY | 38.77 Million USD | 12.78% |
| 2019 Q1 | 7.12 Million USD | -20.61% |
| 2019 FY | 34.37 Million USD | 21.26% |
| 2019 Q2 | 7.64 Million USD | 7.34% |
| 2019 Q3 | 9.65 Million USD | 26.33% |
| 2019 Q4 | 9.94 Million USD | 2.98% |
| 2018 Q1 | 5.96 Million USD | -12.72% |
| 2018 Q2 | 7.64 Million USD | 28.17% |
| 2018 FY | 28.34 Million USD | 60.1% |
| 2018 Q3 | 5.76 Million USD | -24.67% |
| 2018 Q4 | 8.97 Million USD | 55.76% |
| 2017 Q3 | 4.08 Million USD | 4.91% |
| 2017 FY | 17.7 Million USD | 12.46% |
| 2017 Q1 | 2.89 Million USD | -50.75% |
| 2017 Q2 | 3.88 Million USD | 34.18% |
| 2017 Q4 | 6.83 Million USD | 67.52% |
| 2016 Q2 | 3.66 Million USD | 27.85% |
| 2016 Q1 | 2.86 Million USD | -14.5% |
| 2016 FY | 15.74 Million USD | 41.25% |
| 2016 Q4 | 5.88 Million USD | 77.11% |
| 2016 Q3 | 3.32 Million USD | -9.36% |
| 2015 Q4 | 3.35 Million USD | 29.87% |
| 2015 FY | 11.14 Million USD | 34.46% |
| 2015 Q3 | 2.58 Million USD | 1.44% |
| 2015 Q2 | 2.54 Million USD | -18.17% |
| 2015 Q1 | 3.11 Million USD | -13.55% |
| 2014 Q3 | 2.24 Million USD | 62.34% |
| 2014 Q2 | 1.38 Million USD | 30.13% |
| 2014 Q1 | 1.06 Million USD | 121.09% |
| 2014 FY | 8.29 Million USD | 128.79% |
| 2014 Q4 | 3.59 Million USD | 60.35% |
| 2013 Q4 | 480.59 Thousand USD | 3.85% |
| 2013 Q1 | 1.34 Million USD | 701.97% |
| 2013 Q2 | 1.33 Million USD | -0.71% |
| 2013 Q3 | 462.78 Thousand USD | -65.34% |
| 2013 FY | 3.62 Million USD | 9.04% |
| 2012 FY | 3.32 Million USD | -25.51% |
| 2012 Q1 | 1.07 Million USD | 8.19% |
| 2012 Q3 | 1.06 Million USD | 3.12% |
| 2012 Q2 | 1.03 Million USD | -3.87% |
| 2012 Q4 | 167.68 Thousand USD | -84.25% |
| 2011 Q4 | 992.75 Thousand USD | -19.0% |
| 2011 Q1 | 1.12 Million USD | 181.27% |
| 2011 Q2 | 1.11 Million USD | -1.27% |
| 2011 Q3 | 1.22 Million USD | 10.01% |
| 2011 FY | 4.46 Million USD | 57.97% |
| 2010 Q2 | 674.37 Thousand USD | -30.32% |
| 2010 Q4 | 401.2 Thousand USD | -48.61% |
| 2010 Q3 | 780.65 Thousand USD | 15.76% |
| 2010 FY | 2.82 Million USD | -6.72% |
| 2010 Q1 | 967.77 Thousand USD | 70.41% |
| 2009 Q4 | 567.9 Thousand USD | -32.44% |
| 2009 Q2 | 853.27 Thousand USD | 11.45% |
| 2009 Q1 | 765.62 Thousand USD | -16.41% |
| 2009 FY | 3.02 Million USD | -6.68% |
| 2009 Q3 | 840.56 Thousand USD | -1.49% |
| 2008 Q2 | -811.29 Thousand USD | -225.48% |
| 2008 FY | 3.24 Million USD | 5.79% |
| 2008 Q1 | 646.57 Thousand USD | 7.19% |
| 2008 Q4 | 915.97 Thousand USD | 5.24% |
| 2008 Q3 | 870.33 Thousand USD | 207.28% |
| 2007 Q2 | 617.9 Thousand USD | -46.7% |
| 2007 FY | 3.06 Million USD | 3.45% |
| 2007 Q4 | 603.21 Thousand USD | -12.09% |
| 2007 Q3 | 686.15 Thousand USD | 11.04% |
| 2007 Q1 | 1.15 Million USD | 28.39% |
| 2006 Q4 | 903.02 Thousand USD | 35.07% |
| 2006 Q1 | 10.76 Thousand USD | -18.05% |
| 2006 Q3 | 668.54 Thousand USD | 14.98% |
| 2006 FY | 2.96 Million USD | 3605.39% |
| 2006 Q2 | 581.44 Thousand USD | 5302.27% |
| 2005 FY | 80 Thousand USD | 0.0% |
| 2005 Q4 | 13.13 Thousand USD | -4.73% |
| 2005 Q3 | 13.78 Thousand USD | -54.05% |
| 2005 Q2 | 30 Thousand USD | 50.0% |
| 2005 Q1 | 20 Thousand USD | -32.13% |
| 2004 Q4 | 29.46 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -330.656% |
| Cerus Corporation | 143.15 Million USD | 66.235% |
| OrthoPediatrics Corp. | 137.01 Million USD | 64.723% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -325.468% |
| Talis Biomedical Corporation | 67.18 Million USD | 28.055% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -93.766% |
| Inogen, Inc. | 236.08 Million USD | 79.526% |
| Spectral AI, Inc. | 20.86 Million USD | -131.676% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 13.68% |
| CVRx, Inc. | 76.14 Million USD | 36.517% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1270.094% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -287.035% |
| Orthofix Medical Inc. | 667.42 Million USD | 92.758% |
| Venus Concept Inc. | 80.47 Million USD | 39.936% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 14.566% |
| Bioventus Inc. | 409.91 Million USD | 88.208% |
| BrainsWay Ltd. | 28.01 Million USD | -72.521% |
| Envoy Medical, Inc. | 17.89 Million USD | -170.068% |
| electroCore, Inc. | 32.03 Million USD | -50.906% |
| IceCure Medical Ltd | 16.87 Million USD | -186.424% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -13.916% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -174.127% |
| MaxCyte, Inc. | 84.84 Million USD | 43.029% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -289.444% |
| Nexalin Technology, Inc. | 5.78 Million USD | -736.082% |
| PAVmed Inc | 64.82 Million USD | 25.437% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 5.367% |
| RxSight, Inc. | 103.85 Million USD | 53.455% |
| Sight Sciences, Inc. | 126.44 Million USD | 61.774% |
| SI-BONE, Inc. | 156.35 Million USD | 69.084% |
| TELA Bio, Inc. | 84.18 Million USD | 42.584% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 31.003% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 76.231% |
| LivaNova PLC | 843.54 Million USD | 94.27% |
| 908 Devices Inc. | 68.08 Million USD | 29.0% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 90.005% |
| Nemaura Medical Inc. | 7.13 Million USD | -577.1% |
| NeuroPace, Inc. | 75.29 Million USD | 35.804% |
| LENSAR, Inc. | 33.33 Million USD | -44.999% |
| Apyx Medical Corporation | 51.01 Million USD | 5.255% |
| Cutera, Inc. | 197.72 Million USD | 75.553% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -95.056% |
| BioSig Technologies, Inc. | 28.53 Million USD | -69.425% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 74.756% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -34.046% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 94.221% |
| Axonics, Inc. | 270.2 Million USD | 82.111% |
| Outset Medical, Inc. | 198.77 Million USD | 75.682% |
| IRIDEX Corporation | 31.81 Million USD | -51.936% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 73.179% |
| IRadimed Corporation | 30.12 Million USD | -60.466% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -466.536% |
| INVO Bioscience, Inc. | 7.85 Million USD | -515.498% |
| Telesis Bio, Inc. | 63.48 Million USD | 23.866% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 50.904% |
| Varex Imaging Corporation | 224.8 Million USD | 78.498% |
| Quipt Home Medical Corp. | 148.66 Million USD | 67.486% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -312.325% |
| Pulmonx Corporation | 112.68 Million USD | 57.105% |
| Dynatronics Corporation | 9.9 Million USD | -387.856% |
| Modular Medical, Inc. | 17.52 Million USD | -175.754% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -139.445% |
| Semler Scientific, Inc. | 38.94 Million USD | -24.119% |
| InMode Ltd. | 215.68 Million USD | 77.589% |
| Bruker Corporation | 1.07 Billion USD | 95.509% |
| DexCom, Inc. | 1.69 Billion USD | 97.142% |
| Align Technology, Inc. | 2.07 Billion USD | 97.673% |
| Viveve Medical, Inc. | 22.17 Million USD | -117.999% |
| ZimVie Inc. | 275.12 Million USD | 82.431% |
| Movano Inc. | 29.69 Million USD | -62.805% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 64.787% |
| Nexalin Technology, Inc. | 5.78 Million USD | -736.082% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1270.094% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 91.956% |
| Profound Medical Corp. | 33.6 Million USD | -43.846% |
| Insulet Corporation | 939.9 Million USD | 94.857% |
| enVVeno Medical Corporation | 25.23 Million USD | -91.524% |
| Surmodics, Inc. | 98.69 Million USD | 51.025% |
| iCAD, Inc. | 22.22 Million USD | -117.489% |
| Nuwellis, Inc. | 22.61 Million USD | -113.757% |
| Biotricity, Inc. | 17.18 Million USD | -181.281% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 89.159% |
| Aethlon Medical, Inc. | 12.27 Million USD | -293.702% |
| InspireMD, Inc. | 22.95 Million USD | -110.618% |
| PAVmed Inc. | 64.82 Million USD | 25.437% |
| BIOLASE, Inc. | 34.66 Million USD | -39.456% |
| Beyond Air, Inc. | 61.7 Million USD | 21.658% |
| FONAR Corporation | 28.6 Million USD | -68.982% |
| AxoGen, Inc. | 149.33 Million USD | 67.632% |
| Vivani Medical, Inc. | 26.96 Million USD | -79.258% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 72.705% |
| Inari Medical, Inc. | 448.59 Million USD | 89.225% |
| UFP Technologies, Inc. | 58.08 Million USD | 16.788% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -880.941% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -665.031% |
| Tenon Medical, Inc. | 16.96 Million USD | -184.871% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -553.819% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -9.6% |
| AdaptHealth Corp. | 1.07 Billion USD | 95.516% |
| Sintx Technologies, Inc. | 15.2 Million USD | -217.985% |
| NanoVibronix, Inc. | 4.97 Million USD | -871.986% |
| Quanterix Corporation | 118.1 Million USD | 59.071% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -312.325% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -234.696% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 87.69% |
| TransMedics Group, Inc. | 182.82 Million USD | 73.56% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -72.232% |
| NeuroMetrix, Inc. | 11.09 Million USD | -335.509% |
| Hyperfine, Inc. | 52.87 Million USD | 8.578% |
| Establishment Labs Holdings Inc. | 172 Million USD | 71.898% |
| Biomerica, Inc. | 6.97 Million USD | -592.703% |
| Bone Biologics Corporation | 9.42 Million USD | -412.678% |
| AVITA Medical, Inc. | 80.77 Million USD | 40.162% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -368.779% |
| Silk Road Medical, Inc | 186.35 Million USD | 74.062% |